Effects of reversal of neuromuscular blockades on QT dispersion under profpofol anesthesia

Effects of reversal of neuromuscular blockades on QT dispersion under profpofol anesthesia - Effects of reversal of neuromuscular blockades on QT dispersion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024742

Enrollment

Registered

2016-11-10

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who scheduled to undergo elective otorhinolaryngological surgery

Interventions

After the operation,sugammadexare given, then QT and QTD are measured by 12-lead ECG. After the operation,neostignmine are given, then QT and QTD are measured by 12-lead ECG.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA physical status I or II patients who are scheduled to undergo elective otorhinolaryngological surgery are studied.

Exclusion criteria

Exclusion criteria: All patients with cardiovascular respiratory, metabolic or cerebrovascular disease were excluded. Patients with predicted difficulty in tracheal intubation were also excluded.

Design outcomes

Primary

Measure	Time frame
After the operation, sugammadex or neostigmine are given, then QT and QT dispersion are measured.	—

Countries

Japan

Contacts

Public ContactToshifumi Takasusuki

Dokkyo Medical University Anesthesiology

takasusu@dokkyomed.ac.jp0282-86-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026